Niche-based screening identifies small-molecule inhibitors of leukemia stem cells

被引:1
|
作者
Hartwell, Kimberly A. [1 ,2 ,3 ]
Miller, Peter G. [2 ,3 ]
Mukherjee, Siddhartha [4 ,5 ]
Kahn, Alissa R. [6 ]
Stewart, Alison L. [1 ]
Logan, David J. [1 ]
Negri, Joseph M. [1 ]
Duvet, Mildred [1 ,4 ,5 ]
Jaeras, Marcus [2 ,3 ]
Puram, Rishi [2 ,3 ]
Dancik, Vlado [1 ]
Al-Shahrour, Fatima [1 ,2 ,3 ]
Kindler, Thomas [2 ,3 ]
Tothova, Zuzana [2 ,3 ]
Chattopadhyay, Shrikanta [1 ,7 ]
Hasaka, Thomas [1 ]
Narayan, Rajiv [1 ]
Dai, Mingji [1 ,8 ]
Huang, Christina [1 ]
Shterental, Sebastian [2 ,3 ]
Chu, Lisa P. [2 ,3 ]
Haydu, J. Erika [2 ,3 ]
Shieh, Jae Hung [6 ]
Steensma, David P. [3 ,9 ]
Munoz, Benito [1 ]
Bittker, Joshua A. [1 ]
Shamji, Alykhan F. [1 ]
Clemons, Paul A. [1 ]
Tolliday, Nicola J. [1 ]
Carpenter, Anne E. [1 ]
Gilliland, D. Gary [1 ,2 ,3 ,9 ,10 ]
Stern, Andrew M. [1 ]
Moore, Malcolm A. S. [11 ]
Scadden, David T. [1 ,4 ,5 ,7 ]
Schreiber, Stuart L. [1 ,8 ,10 ]
Ebert, Benjamin L. [1 ,2 ,3 ,9 ]
Golub, Todd R. [1 ,3 ,10 ,12 ]
机构
[1] Broad Inst, Cambridge, MA 02142 USA
[2] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[6] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
[7] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA
[8] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA
[9] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[10] Harvard Univ, Howard Hughes Med Inst, Sch Med, Chevy Chase, MD USA
[11] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[12] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
ACUTE MYELOID-LEUKEMIA; PROGENITOR CELLS; STROMAL CELLS; PROTEIN TRANSFERASE; FREQUENCY-ANALYSIS; INDUCED APOPTOSIS; IN-VIVO; CANCER; GENES; MICE;
D O I
10.1038/NCHEMBIO.1367
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Efforts to develop more effective therapies for acute leukemia may benefit from high-throughput screening systems that reflect the complex physiology of the disease, including leukemia stem cells (LSCs) and supportive interactions with the bone marrow microenvironment. The therapeutic targeting of LSCs is challenging because LSCs are highly similar to normal hematopoietic stem and progenitor cells (HSPCs) and are protected by stromal cells in vivo. We screened 14,718 compounds in a leukemia-stroma co-culture system for inhibition of cobblestone formation, a cellular behavior associated with stem-cell function. Among those compounds that inhibited malignant cells but spared HSPCs was the cholesterol-lowering drug lovastatin. Lovastatin showed anti-LSC activity in vitro and in an in vivo bone marrow transplantation model. Mechanistic studies demonstrated that the effect was on target, via inhibition of HMG-CoA reductase. These results illustrate the power of merging physiologically relevant models with high-throughput screening.
引用
收藏
页码:840 / +
页数:12
相关论文
共 50 条
  • [21] An in vivo multiplexed small-molecule screening platform
    Gruner, Barbara M.
    Schulze, Christopher J.
    Yang, Dian
    Ogasawara, Daisuke
    Dix, Melissa M.
    Rogers, Zoe N.
    Chuang, Chen-Hua
    McFarland, Christopher D.
    Chiou, Shin-Heng
    Brown, J. Mark
    Cravatt, Benjamin F.
    Bogyo, Matthew
    Winslow, Monte M.
    NATURE METHODS, 2016, 13 (10) : 883 - +
  • [22] Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells
    Tremblay, Cedric S.
    Chiu, Sung Kai
    Saw, Jesslyn
    McCalmont, Hannah
    Litalien, Veronique
    Boyle, Jacqueline
    Sonderegger, Stefan E.
    Chau, Ngoc
    Evans, Kathryn
    Cerruti, Loretta
    Salmon, Jessica M.
    McCluskey, Adam
    Lock, Richard B.
    Robinson, Phillip J.
    Jane, Stephen M.
    Curtis, David J.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [23] Small-Molecule Inhibitors of USP1 Target ID1 Degradation in Leukemic Cells
    Mistry, Helena
    Hsieh, Grace
    Buhrlage, Sara J.
    Huang, Min
    Park, Eunmi
    Cuny, Gregory D.
    Galinsky, Ilene
    Stone, Richard M.
    Gray, Nathanael S.
    D'Andrea, Alan D.
    Parmar, Kalindi
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (12) : 2651 - 2662
  • [24] The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment
    Greim, Helmut
    Kaden, Debra A.
    Larson, Richard A.
    Palermo, Christine M.
    Rice, Jerry M.
    Ross, David
    Snyder, Robert
    BONE MARROW NICHE, STEM CELLS, AND LEUKEMIA: IMPACT OF DRUGS, CHEMICALS, AND THE ENVIRONMENT, 2014, 1310 : 7 - 31
  • [25] Small-Molecule Inhibitors Targeting Lipolysis in Human Adipocytes
    Grabner, Gernot F.
    Guttenberger, Nikolaus
    Mayer, Nicole
    Migglautsch-Sulzer, Anna K.
    Lembacher-Fadum, Christian
    Fawzy, Nermeen
    Bulfon, Dominik
    Hofer, Peter
    Zuellig, Thomas
    Hartig, Lennart
    Kulminskaya, Natalia
    Chalhoub, Gabriel
    Schratter, Margarita
    Radner, Franz P. W.
    Preiss-Landl, Karina
    Masser, Sarah
    Lass, Achim
    Zechner, Rudolf
    Gruber, Karl
    Oberer, Monika
    Breinbauer, Rolf
    Zimmermann, Robert
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (14) : 6237 - 6250
  • [26] Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors
    Zhang, Yi
    Rong, Deqin
    Li, Bingbing
    Wang, Yuanxiang
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (12) : 7900 - 7925
  • [27] Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput Screening
    Otsuka, Yuka
    Airola, Michael, V
    Choi, Yong-Mi
    Coant, Nicolas
    Snider, Justin
    Cariello, Chris
    Saied, Essa M.
    Arenz, Christoph
    Bannister, Thomas
    Rahaim, Ron, Jr.
    Hannun, Yusuf A.
    Shumate, Justin
    Scampavia, Louis
    Haley, John D.
    Spicer, Timothy P.
    SLAS DISCOVERY, 2021, 26 (01) : 113 - 121
  • [28] Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem-and progenitor cells in acute myeloid leukemia (AML)
    Herrmann, Harald
    Blatt, Katharina
    Shi, Junwei
    Gleixner, Karoline V.
    Cerny-Reiterer, Sabine
    Muellauer, Leonhard
    Vakoc, Christopher R.
    Sperr, Wolfgang R.
    Horny, Hans-Peter
    Bradner, James E.
    Zuber, Johannes
    Valent, Peter
    ONCOTARGET, 2012, 3 (12) : 1588 - 1599
  • [29] The development of small-molecule inhibitors targeting hexokinase 2
    Shan, Wenying
    Zhou, Yan
    Tam, Kin Yip
    DRUG DISCOVERY TODAY, 2022, 27 (09) : 2574 - 2585
  • [30] SMALL-MOLECULE INHIBITORS bULKing up mTOR inhibition
    Goodwin, Jonathan M.
    Murphy, Leon O.
    NATURE CHEMICAL BIOLOGY, 2015, 11 (10) : 758 - 760